OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
EFO: Experimental Factor Ontology
ABL1 (human)
ABL1/CC2D1A protein level ratio in blood
ABL1/DNMBP protein level ratio in blood
ABL1/PDLIM7 protein level ratio in blood
ABL1/TBC1D23 protein level ratio in blood
accelerated phase myeloid leukemia
amount of tyrosine-protein kinase ABL1 (human) in blood
atypical chronic myeloid leukemia, BCR-ABL1 negative
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
CDK5 and ABL1 enzyme substrate 2
CDK5 and ABL1 enzyme substrate 2 (human)
chronic myelogenous leukemia
level of CDK5 and ABL1 enzyme substrate 2 (human) in cerebrospinal fluid
level of CDK5 and ABL1 enzyme substrate 2 in blood serum
level of tyrosine-protein kinase ABL1 (human) in cerebrospinal fluid
tyrosine-protein kinase ABL1
tyrosine-protein kinase ABL1 (human)
tyrosine-protein kinase ABL1 measurement
GO: Molecular Function
protein serine/threonine kinase activity
protein tyrosine kinase activity
OBA: Ontology of Biological Attributes
ABL1/CC2D1A protein level ratio in blood
ABL1/DNMBP protein level ratio in blood
ABL1/PDLIM7 protein level ratio in blood
ABL1/TBC1D23 protein level ratio in blood
amount of tyrosine-protein kinase ABL1 (human) in blood
level of CDK5 and ABL1 enzyme substrate 2 in blood serum
RDO: RGD Disease Ontology
acute myeloid leukemia with BCR-ABL1
atypical chronic myeloid leukemia, BCR-ABL1 negative
B-lymphoblastic leukemia/lymphoma with BCR-ABL1
B-lymphoblastic leukemia/lymphoma, BCR-ABL1-like
chronic myelogenous leukemia, BCR-ABL1 positive
chronic myeloid leukemia
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME
mixed phenotype acute leukemia with BCR-ABL1
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||



















